Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

AbbVie is aiming to position Vuity as a first-line option for people newly-diagnosed with mild-to-moderate presbyopia, either as an alternative to reading glasses or as an add-on that can give ...

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Paul Smith of Orasis Pharmaceuticals discusses the benefits that Qlosi provides patients with presbyopia. KOLOA ...

LENZ Therapeutics (formerly Presbyopia Therapies) is working on eyedrops containing aceclidine – thought to act like pilocarpine as a miotic agent, reducing eye pressure – showed improvements ...

008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...

Tenpoint plans to submit an FDA new drug application in the first half of 2025. Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase ...

The Drugs Controller General of India (DCGI) has granted approval to Entod Pharmaceuticals’ innovative PresVu eye drops, ...

The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, BRIMOCHOL™ PF, on track for NDA filing in 1H, 2025, with a promising pipeline of innovative ...